Two centuries. Countless innovations. One vision.
Takeda and Seagen to Highlight ADCETRIS® Combination Data Showing Statistically Significant Improvement in Overall Survival (OS) for Patients with Advanced Hodgkin Lymphoma
Continuation of the Stock Compensation Plan for Directors and the Stock Grant System for Company Management in Japan in Fiscal Year 2022
Takeda Delivers Strong FY2021 Results; Continued Growth Momentum Expected in FY2022
Takeda Recognized as 2022 ISPE Facility of the Year Awards Winner in Two Categories
Takeda Holds Fourth Quarter and Full-Year FY2021 Earnings Call on May 11
SEE ALL NEWS AND RELEASES >
・For Shire news releases, click here
Luck is not a strategy: The world needs to start preparing now for the next pandemic
The COVID-19 Mental Burden on Working Mothers
Takeda Neuroscience at the Annual Meeting of the American Academy of Neurology (AAN) 2021
Takeda Breaks Ground on Commercial Cell Therapy Manufacturing Facility in Lexington, Massachusetts
Spotlight Malawi: Many Paths Towards Universal Health Coverage and a Strong Health Workforce
SEE ALL FEATURED TOPICS ARTICLES >
With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.
For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.
Copyright 1995-2022 Takeda Pharmaceutical Company Limited. All rights reserved.